p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples